【ChiCTR2100044537】SHOCK INDEX AS A PROGNOSTICATOR FOR EMERGENT SURGICAL INTERVENTION AND MORTALITY IN TRAUMA PATIENTS AT A TERTIARY HOSPITAL IN JOHANNESBURG: A MEDICAL RECORDS BASED RETROSPECTIVE COHORT REVIEW
ChiCTR2100044537
结束
/
/
/
2021-03-23
/
/
Trauma
SHOCK INDEX AS A PROGNOSTICATOR FOR EMERGENT SURGICAL INTERVENTION AND MORTALITY IN TRAUMA PATIENTS AT A TERTIARY HOSPITAL IN JOHANNESBURG: A MEDICAL RECORDS BASED RETROSPECTIVE COHORT REVIEW
SHOCK INDEX AS A PROGNOSTICATOR FOR EMERGENT SURGICAL INTERVENTION AND MORTALITY IN TRAUMA PATIENTS AT A TERTIARY HOSPITAL IN JOHANNESBURG: A MEDICAL RECORDS BASED RETROSPECTIVE COHORT REVIEW
To describe the demographics (Age, Gender, Population group) of patients presenting to the Trauma Unit. To describe the mechanism of injury (blunt/penetrating) of patients presenting to the Trauma Unit and their relationship to SI. To describe the distribution of anatomical regions and initial physiological parameters of injuries in terms of Injury Severity scores. To evaluate the relationship between the SI and need for emergent surgical intervention To describe the type of emergent surgical intervention performed. To describe the relationship between SI and in-hospital mortality.
连续入组
回顾性研究
N/A
N/A
Private
/
1523
/
2018-11-01
2021-02-01
/
All records of patients over the age of 18 years old who were trauma team activations；
请登录查看Patients declared Dead on Arrival or whose injuries are deemed non-survivable; All isolated Traumatic Brain Injury (TBI) patients and Isolated Thermal/Chemical Injuries; All patients taken for surgery for isolated Orthopaedic procedures where by the procedure is not related to the control of haemorrhage; Patients whose physiological response to hypovolemia will be altered such as those known to be on rate control medications / pace makers or started on inotropes prior to hospital admission; Patients referred in from another hospital; Patients discharged / who sign refusal of hospital treatment or abscond without admission to the unit for further treatment.；
请登录查看Dr Richard Allan Crawford
/
Dr Richard Allan Crawford的其他临床试验
南非约翰内斯堡University of Witwatersrand的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29